HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kun Song Selected Research

hematoporphyrin monomethyl ether

10/2011Intracellular metabolism, subcellular localization and phototoxicity of HMME/HB in ovarian cancer cells.
12/2007Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether.
11/2007Involvement of mitochondria-caspase pathway in Hemoporfin-mediated cell death.
9/2006[Photodynamic effect of hematoporphyrin monomethyl ether on ovarian cancer cell line SKOV3].
11/2005Phototoxicity of Hemoporfin to ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kun Song Research Topics

Disease

47Neoplasms (Cancer)
05/2022 - 11/2005
17Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 11/2005
14Inflammation (Inflammations)
10/2021 - 09/2013
10Non-alcoholic Fatty Liver Disease
01/2022 - 11/2016
9Infections
10/2022 - 01/2018
8Hypertension (High Blood Pressure)
12/2021 - 11/2013
8Type 2 Diabetes Mellitus (MODY)
03/2019 - 05/2015
6Virus Diseases (Viral Diseases)
10/2022 - 03/2015
6Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 01/2012
6Hyperuricemia
10/2021 - 02/2013
6Carcinogenesis
01/2019 - 01/2014
5Obesity
01/2022 - 08/2017
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2017
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 03/2012
4Neoplasm Metastasis (Metastasis)
09/2021 - 05/2016
4Body Weight (Weight, Body)
08/2019 - 01/2017
4Ovarian Epithelial Carcinoma
10/2017 - 11/2005
3Hypothyroidism
12/2021 - 01/2016
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2020
3Prediabetic State (Prediabetes)
03/2020 - 08/2016
3Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2018
3Necrosis
11/2007 - 11/2005
2Critical Illness (Critically Ill)
03/2022 - 08/2021
2Bites and Stings (Sting)
01/2022 - 10/2021
2Bacterial Infections (Bacterial Infection)
01/2022 - 10/2021
2Hypertriglyceridemia
11/2021 - 12/2015
2Hypoxia (Hypoxemia)
09/2021 - 09/2019
2Hypertrophy
01/2021 - 01/2021
2Carcinoma (Carcinomatosis)
01/2021 - 09/2006
2Dyslipidemias (Dyslipidemia)
10/2020 - 11/2016
2Glucose Intolerance
03/2020 - 08/2016
2Prehypertension
01/2020 - 01/2017
2Lymphoma (Lymphomas)
03/2019 - 03/2015
2Hyperglycemia
01/2019 - 01/2019
2Carotid Artery Diseases
01/2019 - 06/2017
2Fibrosis (Cirrhosis)
01/2018 - 01/2018
2Metabolic Diseases (Metabolic Disease)
01/2018 - 12/2016
2Adenocarcinoma
09/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2014
10Uric Acid (Urate)IBA
10/2021 - 03/2012
8Glucose (Dextrose)FDA LinkGeneric
03/2020 - 07/2011
6Thyroid HormonesIBA
01/2022 - 12/2015
6Pharmaceutical PreparationsIBA
08/2021 - 09/2015
61-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2018 - 11/2005
5CytokinesIBA
02/2022 - 09/2013
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2017
5Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2022 - 12/2015
5Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2014
5AntioxidantsIBA
01/2021 - 01/2020
5Immunoglobulins (Immunoglobulin)IBA
01/2019 - 03/2015
5hematoporphyrin monomethyl etherIBA
10/2011 - 11/2005
4Biomarkers (Surrogate Marker)IBA
05/2022 - 08/2015
4Biological ProductsIBA
02/2022 - 09/2017
4LipidsIBA
01/2022 - 11/2016
4Antiviral Agents (Antivirals)IBA
01/2022 - 03/2015
4ORALIT (ORS)IBA
12/2021 - 01/2020
4CholesterolIBA
11/2021 - 01/2019
4Photosensitizing Agents (Photosensitizers)IBA
06/2018 - 11/2005
4Immunoglobulin M (IgM)IBA
01/2018 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
10/2022 - 11/2007
3Therapeutic UsesIBA
01/2022 - 01/2020
3Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2022 - 08/2019
3Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022 - 08/2019
3Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021 - 01/2020
3Leucine (L-Leucine)FDA Link
09/2021 - 03/2015
3Beclin-1IBA
03/2019 - 01/2014
3hypocrellin BIBA
06/2018 - 10/2011
3Complement C3 (C3 Complement)IBA
01/2018 - 01/2015
3MicroRNAs (MicroRNA)IBA
09/2017 - 11/2014
3GoldIBA
07/2014 - 07/2011
2ChromatinIBA
10/2022 - 01/2021
2SugarsIBA
10/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021 - 09/2019
2Paclitaxel (Taxol)FDA LinkGeneric
08/2021 - 02/2018
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2021
2QuercetinIBA
01/2021 - 03/2019
2Propranolol (Inderal)FDA LinkGeneric
01/2021 - 01/2020
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 01/2020
2LDL CholesterolIBA
10/2020 - 12/2015
2HDL CholesterolIBA
10/2020 - 01/2014
2NucleoproteinsIBA
01/2020 - 01/2018
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020 - 01/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2019 - 03/2017
2Bone Marrow Stromal Antigen 2IBA
03/2019 - 03/2015
2Alanine Transaminase (SGPT)IBA
09/2018 - 11/2016
2Indicators and Reagents (Reagents)IBA
07/2018 - 11/2015
2monomethoxypolyethyleneglycol- polylactide block copolymerIBA
06/2018 - 02/2018
2Immunoglobulin A (IgA)IBA
01/2018 - 01/2017
2Glycoproteins (Glycoprotein)IBA
01/2018 - 05/2016
2S100 Calcium-Binding Protein A4IBA
01/2018 - 03/2017
2Immunoglobulin G (IgG)IBA
01/2018 - 01/2017
2Immunoglobulin E (IgE)IBA
01/2018 - 01/2017
2Ferritins (Ferritin)IBA
06/2017 - 01/2016

Therapy/Procedure

18Therapeutics
01/2022 - 12/2007
6Drug Therapy (Chemotherapy)
01/2021 - 09/2011
6Photochemotherapy (Photodynamic Therapy)
06/2018 - 11/2005
3Lymph Node Excision (Lymph Node Dissection)
07/2022 - 01/2012
3Radiotherapy
07/2014 - 07/2011
2Length of Stay
08/2021 - 01/2011
2Neoadjuvant Therapy
01/2021 - 10/2017